TELETRADER News
7/20, 3:40 PM (Source: TeleTrader)
more TeleTrader news

Oxford COVID-19 vaccine creates immune response

A COVID-19 vaccine candidate jointly developed by Oxford University and AstraZeneca is producing the desired immune response and is safe for humans, preliminary research showed on Monday.

"ChAdOx1 nCoV-19 showed an acceptable safety profile, and homologous boosting increased antibody responses. These results, together with the induction of both humoral and cellular immune responses, support largescale evaluation of this candidate vaccine in an ongoing phase 3 program," the report noted explaining the trial findings.

The vaccine is "safe and tolerated," according to the research, with scientists advising that "further clinical studies, including in older adults, should be done with this vaccine."

Breaking the News / ND